194 related articles for article (PubMed ID: 10209286)
1. The role of the non-conserved residue at position 104 of class A beta-lactamases in susceptibility to mechanism-based inhibitors.
Guo F; Huynh J; Dmitrienko GI; Viswanatha T; Clarke AJ
Biochim Biophys Acta; 1999 Apr; 1431(1):132-47. PubMed ID: 10209286
[TBL] [Abstract][Full Text] [Related]
2. The role of the nonconserved residues at position 167 of class A beta-lactamases in susceptibility to mechanism-based inhibitors.
Guo F; Dmitrienko GI; Clarke AJ; Viswanatha T
Microb Drug Resist; 1996; 2(2):261-8. PubMed ID: 9158770
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactamases as fully efficient enzymes. Determination of all the rate constants in the acyl-enzyme mechanism.
Christensen H; Martin MT; Waley SG
Biochem J; 1990 Mar; 266(3):853-61. PubMed ID: 2158301
[TBL] [Abstract][Full Text] [Related]
4. OHIO-1 beta-lactamase mutants: the Arg244Ser mutant and resistance to beta-lactams and beta-lactamase inhibitors.
Lin S; Thomas M; Mark S; Anderson V; Bonomo RA
Biochim Biophys Acta; 1999 Jun; 1432(1):125-36. PubMed ID: 10366735
[TBL] [Abstract][Full Text] [Related]
5. Structures of the acyl-enzyme complexes of the Staphylococcus aureus beta-lactamase mutant Glu166Asp:Asn170Gln with benzylpenicillin and cephaloridine.
Chen CC; Herzberg O
Biochemistry; 2001 Feb; 40(8):2351-8. PubMed ID: 11327855
[TBL] [Abstract][Full Text] [Related]
6. Structure and kinetics of the beta-lactamase mutants S70A and K73H from Staphylococcus aureus PC1.
Chen CC; Smith TJ; Kapadia G; Wäsch S; Zawadzke LE; Coulson A; Herzberg O
Biochemistry; 1996 Sep; 35(38):12251-8. PubMed ID: 8823158
[TBL] [Abstract][Full Text] [Related]
7. Beta-secondary and solvent deuterium kinetic isotope effects on beta-lactamase catalysis.
Adediran SA; Deraniyagala SA; Xu Y; Pratt RF
Biochemistry; 1996 Mar; 35(11):3604-13. PubMed ID: 8639512
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and mechanism of the serine beta-lactamase catalyzed hydrolysis of depsipeptides.
Govardhan CP; Pratt RF
Biochemistry; 1987 Jun; 26(12):3385-95. PubMed ID: 3115289
[TBL] [Abstract][Full Text] [Related]
9. Site-directed mutagenesis of dicarboxylic acids near the active site of Bacillus cereus 5/B/6 beta-lactamase II.
Lim HM; Iyer RK; Pène JJ
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):401-4. PubMed ID: 1904717
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.
Trehan I; Beadle BM; Shoichet BK
Biochemistry; 2001 Jul; 40(27):7992-9. PubMed ID: 11434768
[TBL] [Abstract][Full Text] [Related]
11. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
[TBL] [Abstract][Full Text] [Related]
12. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
[TBL] [Abstract][Full Text] [Related]
13. Multiple substitutions at position 104 of beta-lactamase TEM-1: assessing the role of this residue in substrate specificity.
Petit A; Maveyraud L; Lenfant F; Samama JP; Labia R; Masson JM
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):33-40. PubMed ID: 7826350
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
Sun T; Bethel CR; Bonomo RA; Knox JR
Biochemistry; 2004 Nov; 43(44):14111-7. PubMed ID: 15518561
[TBL] [Abstract][Full Text] [Related]
15. Conformational changes induced by cloxacillin in class a beta-lactamase from Bacillus cereus.
Salas-Burgos A; Martínez-Oyanedel J; Bunster M
Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):985-90. PubMed ID: 14656057
[TBL] [Abstract][Full Text] [Related]
16. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
[TBL] [Abstract][Full Text] [Related]
17. Mono- and binuclear Zn2+-beta-lactamase. Role of the conserved cysteine in the catalytic mechanism.
Paul-Soto R; Bauer R; Frère JM; Galleni M; Meyer-Klaucke W; Nolting H; Rossolini GM; de Seny D; Hernandez-Valladares M; Zeppezauer M; Adolph HW
J Biol Chem; 1999 May; 274(19):13242-9. PubMed ID: 10224083
[TBL] [Abstract][Full Text] [Related]
18. Phenylpropynal, a specific, irreversible, non-beta-lactam inhibitor of beta-lactamases.
Schenkein DP; Pratt RF
J Biol Chem; 1980 Jan; 255(1):45-8. PubMed ID: 6765945
[TBL] [Abstract][Full Text] [Related]
19. Structure-function relationships among wild-type variants of Staphylococcus aureus beta-lactamase: importance of amino acids 128 and 216.
Voladri RK; Tummuru MK; Kernodle DS
J Bacteriol; 1996 Dec; 178(24):7248-53. PubMed ID: 8955409
[TBL] [Abstract][Full Text] [Related]
20. Replacement of serine 237 in class A beta-lactamase of Proteus vulgaris modifies its unique substrate specificity.
Tamaki M; Nukaga M; Sawai T
Biochemistry; 1994 Aug; 33(33):10200-6. PubMed ID: 8060986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
